Interventions to Improve COVID-19 Vaccine Hesitancy

Nnenna Ezeh, Taussia Boadi, Maria I. Danila, Rosalind Ramsey-Goldman, Candace H. Feldman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish (US)
Pages (from-to)61-73
Number of pages13
JournalRheumatic Disease Clinics of North America
Volume51
Issue number1
DOIs
StatePublished - Feb 2025

Funding

Dr. Feldman: Research Grants: NIH (1OT2HL161841, 1P30AG064199-03, R01AR080089, 30AR072577, R03AR083661, R01MD019235, R01AR074290), the Bristol Myers Squibb Foundation, the Arthritis Foundation, Brigham and Women\u2019s Hospital Health Equity Innovation Pilot. Consulting: Harvard Pilgrim, OM1, Inc., Bain Capital, LP, the American College of Rheumatology, the Lupus Foundation of America, and the University of Alabama. Speaker honorarium (<10K) from University of Texas Southwestern, University of Alabama at Birmingham, Hospital for Special Surgery, University of Washington. Conference travel reimbursement from RLITE Foundation, the Rheumatology Research Foundation, and EULAR. Associate Editor for Lupus Science and Medicine, Editorial Board for Arthritis Care and Research and Medical-Scientific Advisory Board Member for the Lupus Foundation of America. Member of the American College of Rheumatology Diversity, Equity and Inclusion Committee and the Climate Change Task Force. Dr. Danila: Research grants: NIH (P30 AR072583, P50 AR060772, R01 AI153365, R01 AR065493, R01 AR080784) Pfizer, Radius - sums paid to the Institution. Associate Editor for Arthritis Care and Research. Speaker fees <10k. Hospital for special surgery, UT Southwestern, Cedars Sinai, RheumNow.

Keywords

  • Coronavirus disease 2019 infection
  • Coronavirus disease 2019 vaccination
  • Health disparities
  • Preventive care
  • Vaccine hesitancy

ASJC Scopus subject areas

  • Rheumatology

Cite this